Indivior (GB:INDV) has released an update.
Indivior PLC is actively engaging with Oaktree Capital Management to explore proposals aimed at enhancing shareholder value. The Board is committed to maintaining shareholders’ best interests as it continues to implement its strategic objectives. Indivior, a pharmaceutical company, is dedicated to developing treatments for substance use disorders and expanding its global reach.
For further insights into GB:INDV stock, check out TipRanks’ Stock Analysis page.
